{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:05:15Z","timestamp":1761512715682,"version":"3.28.2"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1304.061063","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T21:43:49Z","timestamp":1250718229000},"page":"608-610","source":"Crossref","is-referenced-by-count":29,"title":["Endpoints for Lymphatic Filariasis Programs"],"prefix":"10.3201","volume":"13","author":[{"given":"Caroline A.","family":"Grady","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madsen","family":"Beau de Rochars","sequence":"additional","affiliation":[{"name":"Hopital Ste. Croix, Leogane, Haiti"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel N.","family":"Direny","sequence":"additional","affiliation":[{"name":"Hopital Ste. Croix, Leogane, Haiti"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Nicolas","family":"Orelus","sequence":"additional","affiliation":[{"name":"Hopital Ste. Croix, Leogane, Haiti"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyanna","family":"Wendt","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne","family":"Radday","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els","family":"Mathieu","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquelin M.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G.","family":"Streit","sequence":"additional","affiliation":[{"name":"University of Notre Dame, Notre Dame, Indiana, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Addiss","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Lammie","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","published-online":{"date-parts":[[2007,4]]},"reference":[{"key":"key-10.3201\/eid1304.061063-201205070400-R1","first-page":"491","article-title":"Strategies and tools for the control\/elimination of lymphatic filariasis.","volume":"75","author":"Ottesen","year":"1997","journal-title":"Bull World Health Organ"},{"key":"key-10.3201\/eid1304.061063-201205070400-R2","first-page":"221","article-title":"Global programme to eliminate lymphatic filariasis: progress report on mass drug administrations in 2005.","volume":"81","author":"World Health Organization","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.3201\/eid1304.061063-201205070400-R3","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0140-6736(06)68426-2","article-title":"Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.","volume":"367","author":"Ramzy","year":"2006","journal-title":"Lancet"},{"key":"key-10.3201\/eid1304.061063-201205070400-R4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.pt.2006.05.010","article-title":"Progress toward eliminating lymphatic filariasis in Zanzibar: a model programme.","volume":"22","author":"Mohammed","year":"2006","journal-title":"Trends Parasitol"},{"key":"key-10.3201\/eid1304.061063-201205070400-R5","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4269\/ajtmh.2005.73.888","article-title":"The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.","volume":"73","author":"de Rochars","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid1304.061063-201205070400-R6","doi-asserted-by":"crossref","unstructured":"Goodman DS, Orelus JN, Roberts JM, Lammie PJ, Streit T. PCR and mosquito dissection as tools to monitor filarial infection following mass treatment. Filaria Journal [serial online]. 2003 July; 2(11): [about 9 p.]. Available from http:\/\/www.filariajournal.com\/content\/2\/1\/11.","DOI":"10.1186\/1475-2883-2-11"},{"key":"key-10.3201\/eid1304.061063-201205070400-R7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0035-9203(03)80006-8","article-title":"Comparison of methods for estimating drug coverage for filariasis elimination, Leogane Commune, Haiti.","volume":"97","author":"Mathieu","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.3201\/eid1304.061063-201205070400-R8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1365-3156.2006.01626.x","article-title":"Participation in three consecutive mass drug administrations in Leogane, Haiti.","volume":"11","author":"Mathieu","year":"2006","journal-title":"Trop Med Int Health"},{"key":"key-10.3201\/eid1304.061063-201205070400-R9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4269\/ajtmh.2003.68.568","article-title":"Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.","volume":"68","author":"McLaughlin","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid1304.061063-201205070400-R10","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1086\/378354","article-title":"Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: A simulation study.","volume":"188","author":"Stolk","year":"2003","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1304.061063-201205070400-R11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1473-3099(04)00973-9","article-title":"Mathematical modeling and the control of lymphatic filariasis.","volume":"4","author":"Michael","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid1304.061063-201205070400-R12","doi-asserted-by":"crossref","unstructured":"Lammie P, Weil G, Noordin R, Kaliraj P, Steel C, Goodman D, Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial. Filaria Journal [serial online]. 2004;3(9). Available from http:\/\/www.filariajournal.com\/content\/3\/1\/9.","DOI":"10.1186\/1475-2883-3-9"},{"key":"key-10.3201\/eid1304.061063-201205070400-R13","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1056\/NEJMoa021309","article-title":"Mass treatment to eliminate filariasis in Papua New Guinea.","volume":"347","author":"Bockarie","year":"2002","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1304.061063-201205070400-R14","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1046\/j.1360-2276.2003.01138.x","article-title":"The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.","volume":"8","author":"Ramaiah","year":"2003","journal-title":"Trop Med Int Health"},{"key":"key-10.3201\/eid1304.061063-201205070400-R15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1179\/136485905X19838","article-title":"Significant decrease in the prevalence of Wuchereria bancrofti infection in anopheline mosquitoes following the addition of albendazole to annual ivermectin-based, mass treatments in Nigeria.","volume":"99","author":"Richards","year":"2005","journal-title":"Ann Trop Med Parasitol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/13\/4\/06-1063_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T14:20:10Z","timestamp":1732630810000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/13\/4\/06-1063_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2007,4]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1304.061063","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"type":"print","value":"1080-6040"},{"type":"electronic","value":"1080-6059"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}